Different mechanism of second hit in neurofibromas depending on the germline NF1 mutation
Eric Legius(Center for Human Genetics), Hilde Brems(Center for Human Genetics), Ine Heyns, Ludwine Messiaen(University of Alabama at Birmingham), Joris Vermeesch(KU Leuven), Raf Sciot(KU Leuven), Ophélia Maertens(American Institutes for Research)
European Journal of Human Genetics
January 1, 2005
Cited by 0
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2021|558
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2021|453
Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials
|Journal of Clinical Oncology|2010|401